201 related articles for article (PubMed ID: 16087682)
21. A cytosolic factor that inhibits KATP channels expressed in Xenopus oocytes by impairing Mg-nucleotide activation by SUR1.
Tammaro P; Ashcroft FM
J Physiol; 2009 Apr; 587(Pt 8):1649-56. PubMed ID: 19237428
[TBL] [Abstract][Full Text] [Related]
22. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.
Babenko AP
J Biol Chem; 2008 Apr; 283(14):8778-82. PubMed ID: 18281290
[TBL] [Abstract][Full Text] [Related]
23. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
Hosy E; Dérand R; Revilloud J; Vivaudou M
J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
[TBL] [Abstract][Full Text] [Related]
24. ATP modulation of ATP-sensitive potassium channel ATP sensitivity varies with the type of SUR subunit.
Song DK; Ashcroft FM
J Biol Chem; 2001 Mar; 276(10):7143-9. PubMed ID: 11115512
[TBL] [Abstract][Full Text] [Related]
25. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
Shimomura K; de Nanclares GP; Foutinou C; Caimari M; Castaño L; Ashcroft FM
Diabet Med; 2010 Feb; 27(2):225-9. PubMed ID: 20546268
[TBL] [Abstract][Full Text] [Related]
26. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
[TBL] [Abstract][Full Text] [Related]
27. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
28. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.
Tammaro P; Ashcroft FM
J Physiol; 2007 Nov; 584(Pt 3):743-53. PubMed ID: 17855752
[TBL] [Abstract][Full Text] [Related]
29. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.
Béguin P; Nagashima K; Nishimura M; Gonoi T; Seino S
EMBO J; 1999 Sep; 18(17):4722-32. PubMed ID: 10469651
[TBL] [Abstract][Full Text] [Related]
30. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
[TBL] [Abstract][Full Text] [Related]
31. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
Tucker SJ; Gribble FM; Zhao C; Trapp S; Ashcroft FM
Nature; 1997 May; 387(6629):179-83. PubMed ID: 9144288
[TBL] [Abstract][Full Text] [Related]
32. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit.
Gribble FM; Tucker SJ; Haug T; Ashcroft FM
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7185-90. PubMed ID: 9618560
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
[TBL] [Abstract][Full Text] [Related]
34. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
[TBL] [Abstract][Full Text] [Related]
35. Binding and effect of K ATP channel openers in the absence of Mg2+.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
[TBL] [Abstract][Full Text] [Related]
36. Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.
Vedovato N; Cliff E; Proks P; Poovazhagi V; Flanagan SE; Ellard S; Hattersley AT; Ashcroft FM
Diabetologia; 2016 Jul; 59(7):1430-1436. PubMed ID: 27118464
[TBL] [Abstract][Full Text] [Related]
37. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
38. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
[TBL] [Abstract][Full Text] [Related]
39. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
[TBL] [Abstract][Full Text] [Related]
40. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
